Genomics

Dataset Information

Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated After Starting Hu14.18-IL2 Predicts Outcome


ABSTRACT: Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated After Starting Hu14.18-IL2 Predicts Outcome

PROVIDER: PRJNA595009 | ENA |

REPOSITORIES: ENA